Second Nasdaq Delisting Deficiency Hits Nexalin as Equity Falls Below $2.5M Minimum
NXL is trading near its 52-week low of $0.305 (15% above the low) on light trading volume (0.1× avg).
Summary
A second Nasdaq delisting deficiency was issued to Nexalin Technology for failing to meet the $2.5M minimum stockholders' equity requirement, adding to its existing bid price deficiency. Both will be reviewed at a September 1 hearing.
Key Events · Legal and Risk Events · NXL
-
New Equity Deficiency
On August 14, 2026, Nasdaq notified Nexalin that its stockholders' equity of $1,519,423 (as of June 30, 2026) falls below the $2,500,000 minimum required by Listing Rule 5550(b)(1).
-
Combined Delisting Review
The new equity deficiency will be considered together with the existing bid price deficiency at the Nasdaq Hearing Panel scheduled for September 1, 2026.
-
Delisting Risk
If the Panel rules against Nexalin, its common stock would be delisted from the Nasdaq Capital Market, materially reducing liquidity and impairing its ability to raise capital.
-
Going Concern Context
This deficiency compounds the going concern warning and cash position of $1.0M disclosed in the company's 10-Q filed August 12, 2026.
Analysis · NXL · Industrial Applications And Services
A new Nasdaq delisting deficiency was issued to Nexalin Technology on August 14, 2026, after its June 30, 2026 10-Q reported stockholders' equity of $1,519,423 — below the $2,500,000 minimum required by Listing Rule 5550(b)(1). This comes on top of the bid price deficiency disclosed on July 24, 2026. Both deficiencies will be reviewed at the Nasdaq Hearing Panel on September 1, 2026. Delisting from the Nasdaq Capital Market would severely impair liquidity and the ability to raise capital, compounding the going concern warning already disclosed in the latest 10-Q.
At the time of this filing, NXL was trading at $0.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.7M. The 52-week trading range was $0.31 to $2.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.